318 related articles for article (PubMed ID: 8798512)
1. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
Lengyel E; Wang H; Stepp E; Juarez J; Wang Y; Doe W; Pfarr CM; Boyd D
J Biol Chem; 1996 Sep; 271(38):23176-84. PubMed ID: 8798512
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
[TBL] [Abstract][Full Text] [Related]
3. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
4. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
7. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
[TBL] [Abstract][Full Text] [Related]
10. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor.
Dang J; Boyd D; Wang H; Allgayer H; Doe WF; Wang Y
Eur J Biochem; 1999 Aug; 264(1):92-9. PubMed ID: 10447677
[TBL] [Abstract][Full Text] [Related]
11. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2.
White LA; Brinckerhoff CE
Matrix Biol; 1995 Dec; 14(9):715-25. PubMed ID: 8785586
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor.
Allgayer H; Wang H; Wang Y; Heiss MM; Bauer R; Nyormoi O; Boyd D
J Biol Chem; 1999 Feb; 274(8):4702-14. PubMed ID: 9988707
[TBL] [Abstract][Full Text] [Related]
13. beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.
Hapke S; Gawaz M; Dehne K; Köhler J; Marshall JF; Graeff H; Schmitt M; Reuning U; Lengyel E
Mol Cell Biol; 2001 Mar; 21(6):2118-32. PubMed ID: 11238946
[TBL] [Abstract][Full Text] [Related]
14. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response.
Descheemaeker KA; Wyns S; Nelles L; Auwerx J; Ny T; Collen D
J Biol Chem; 1992 Jul; 267(21):15086-91. PubMed ID: 1634545
[TBL] [Abstract][Full Text] [Related]
15. Novel phorbol ester response region in the collagenase promoter binds Fos and Jun.
Chamberlain SH; Hemmer RM; Brinckerhoff CE
J Cell Biochem; 1993 Jul; 52(3):337-51. PubMed ID: 8366145
[TBL] [Abstract][Full Text] [Related]
16. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene.
Alam J; Den Z
J Biol Chem; 1992 Oct; 267(30):21894-900. PubMed ID: 1400499
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter.
Botelho FM; Edwards DR; Richards CD
J Biol Chem; 1998 Feb; 273(9):5211-8. PubMed ID: 9478976
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-beta site.
Doyle GA; Pierce RA; Parks WC
J Biol Chem; 1997 May; 272(18):11840-9. PubMed ID: 9115242
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.
Lengyel E; Klostergaard J; Boyd D
Biochim Biophys Acta; 1995 Jul; 1268(1):65-72. PubMed ID: 7626664
[TBL] [Abstract][Full Text] [Related]
20. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
Schewe DM; Biller T; Maurer G; Asangani IA; Leupold JH; Lengyel ER; Post S; Allgayer H
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8538-48. PubMed ID: 16361535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
